1/12
08:27 am
twst
Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue [Yahoo! Finance]
Medium
Report
Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue [Yahoo! Finance]
1/12
08:00 am
twst
Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue
Medium
Report
Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue
1/10
07:35 pm
twst
Twist Bioscience (TWST) Valuation Check After TD Cowen Buy Rating And Raised Outlook [Yahoo! Finance]
Medium
Report
Twist Bioscience (TWST) Valuation Check After TD Cowen Buy Rating And Raised Outlook [Yahoo! Finance]
1/8
01:32 pm
twst
Twist Bioscience (NASDAQ:TWST) had its price target raised by analysts at TD Cowen from $32.00 to $43.00. They now have a "buy" rating on the stock.
Low
Report
Twist Bioscience (NASDAQ:TWST) had its price target raised by analysts at TD Cowen from $32.00 to $43.00. They now have a "buy" rating on the stock.
1/8
10:57 am
twst
Twist Bioscience (NASDAQ:TWST) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Low
Report
Twist Bioscience (NASDAQ:TWST) had its "buy" rating reaffirmed by analysts at Cowen Inc.
1/5
11:07 am
twst
Twist Bioscience (NASDAQ:TWST) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Low
Report
Twist Bioscience (NASDAQ:TWST) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
1/1
07:47 am
twst
Barclays Keeps Its Overweight Rating On Twist Bioscience Corporation (TWST) [Yahoo! Finance]
Low
Report
Barclays Keeps Its Overweight Rating On Twist Bioscience Corporation (TWST) [Yahoo! Finance]
12/22
10:37 pm
twst
New Product Launch Strengthens Bull Case for Twist Bioscience ( TWST) [Yahoo! Finance]
Medium
Report
New Product Launch Strengthens Bull Case for Twist Bioscience ( TWST) [Yahoo! Finance]
12/18
08:00 am
twst
Twist Bioscience to Present at J.P. Morgan 2026 Healthcare Conference
Low
Report
Twist Bioscience to Present at J.P. Morgan 2026 Healthcare Conference
12/15
07:20 am
twst
Twist Bioscience (NASDAQ:TWST) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Low
Report
Twist Bioscience (NASDAQ:TWST) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
12/12
01:15 pm
twst
Halper Sadeh LLC Encourages Twist Bioscience Corporation Shareholders to Contact the Firm to Discuss Their Rights
Low
Report
Halper Sadeh LLC Encourages Twist Bioscience Corporation Shareholders to Contact the Firm to Discuss Their Rights
12/6
10:05 am
twst
Atlas Data Storage Announces Eon 100 Synthetic DNA Storage [Forbes]
Low
Report
Atlas Data Storage Announces Eon 100 Synthetic DNA Storage [Forbes]
12/4
07:33 pm
twst
Twist Bioscience (TWST): Valuation Check After New Research-Grade Plasmid DNA Preps Boost Investor Interest [Yahoo! Finance]
Low
Report
Twist Bioscience (TWST): Valuation Check After New Research-Grade Plasmid DNA Preps Boost Investor Interest [Yahoo! Finance]
12/4
08:00 am
twst
Twist Bioscience Launches New Plasmid Preps to Enable Nucleic Acid Therapeutics Research
Medium
Report
Twist Bioscience Launches New Plasmid Preps to Enable Nucleic Acid Therapeutics Research
12/3
09:19 am
twst
Kuehn Law Encourages Investors of Twist Bioscience Corporation to Contact Law Firm
Medium
Report
Kuehn Law Encourages Investors of Twist Bioscience Corporation to Contact Law Firm
11/20
01:40 pm
twst
Twist Bioscience (NASDAQ:TWST) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Twist Bioscience (NASDAQ:TWST) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/19
01:42 pm
twst
Stephens Initiates Twist Bioscience (TWST) With Overweight Rating, Sets $41 PT [Yahoo! Finance]
Low
Report
Stephens Initiates Twist Bioscience (TWST) With Overweight Rating, Sets $41 PT [Yahoo! Finance]
11/18
04:35 pm
twst
Twist Bioscience Is Bent, Not Broken: Near-Term Strain, Long-Term Strength [Seeking Alpha]
Low
Report
Twist Bioscience Is Bent, Not Broken: Near-Term Strain, Long-Term Strength [Seeking Alpha]
11/17
10:23 am
twst
Twist Bioscience (NASDAQ:TWST) had its price target lowered by analysts at Barclays PLC from $40.00 to $37.00. They now have an "overweight" rating on the stock.
Low
Report
Twist Bioscience (NASDAQ:TWST) had its price target lowered by analysts at Barclays PLC from $40.00 to $37.00. They now have an "overweight" rating on the stock.
11/17
10:22 am
twst
Is Twist Bioscience Corporation (TWST) a Compelling Risk-Regarded Opportunity? [Yahoo! Finance]
Low
Report
Is Twist Bioscience Corporation (TWST) a Compelling Risk-Regarded Opportunity? [Yahoo! Finance]
11/17
09:30 am
twst
Can Twist Bioscience Drop More? [Forbes]
Low
Report
Can Twist Bioscience Drop More? [Forbes]
11/16
06:38 am
twst
Twist Bioscience (TWST) Is Down 11.2% After Record Revenue and MRD Express Launch Plans Announced [Yahoo! Finance]
Medium
Report
Twist Bioscience (TWST) Is Down 11.2% After Record Revenue and MRD Express Launch Plans Announced [Yahoo! Finance]
11/14
03:02 pm
twst
Twist Bioscience Corp (TWST) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ... [Yahoo! Finance]
Low
Report
Twist Bioscience Corp (TWST) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ... [Yahoo! Finance]
11/14
01:19 pm
twst
Twist Bioscience (NASDAQ:TWST) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Twist Bioscience (NASDAQ:TWST) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/14
12:04 pm
twst
Twist Bioscience Corporation (TWST) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
Twist Bioscience Corporation (TWST) Q4 2025 Earnings Call Transcript [Seeking Alpha]